282 results on '"Dicklin, Mary R."'
Search Results
2. Evolution of Cardiovascular Outcomes Studies
3. The Imperative to Enhance Cost-Effectiveness for Cardiovascular Therapeutic Development
4. Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN
5. ω-3 Polyunsaturated Fatty Acid Status Testing in Humans: A Narrative Review of Commercially Available Options
6. The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease
7. The Relationship of Ready-to-Eat Cereal Intake and Body Weight in Adults: A Systematic Review of Observational Studies and Controlled Trials
8. The Impact of Ready-to-Eat Cereal Intake on Body Weight and Body Composition in Children and Adolescents: A Systematic Review of Observational Studies and Controlled Trials
9. Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis
10. Epidemiology of Atherosclerotic Cardiovascular Disease
11. Pathophysiology and Management of Dyslipidemias Associated with Insulin-Resistant States
12. Epidemiologic Characterization of Risk for Cardiovascular Diseases
13. Obicetrapib as an Adjunct to Stable Statin Therapy in Japanese Subjects: Results from a Randomized Phase 2 Trial
14. Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
15. Effects of substituting eggs for high-carbohydrate breakfast foods on the cardiometabolic risk-factor profile in adults at risk for type 2 diabetes mellitus
16. Pathophysiology and Management of Dyslipidemias Associated with Insulin-Resistant States
17. Epidemiology of Atherosclerotic Cardiovascular Disease
18. Effects of a Self–micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State
19. ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps
20. Omega-3 fatty acid therapy for cardiovascular disease: justified or not?
21. Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia
22. Trends and Patterns of Chickpea Consumption among United States Adults: Analyses of National Health and Nutrition Examination Survey Data
23. Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables
24. Epidemiologic Characterization of Risk for Cardiovascular Diseases
25. Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates
26. Caution Against Rejecting All Dietary Supplements for LDL Cholesterol Reduction
27. Statins and Diabetes
28. Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: Results from a randomized controlled feeding trial
29. Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels
30. Is there an optimal diet for primordial prevention of atherosclerosis?
31. Assessing Cardiovascular Disease Risk and Responses to Preventive Therapies in Clinical Practice
32. Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia
33. Do triglyceride-lowering drugs decrease risk of cardiovascular disease?
34. Treatment options for the management of hypertriglyceridemia: Strategies based on the best-available evidence
35. Absorption of Folic Acid from a Softgel Capsule Compared to a Standard Tablet
36. Fibre and micronutrient intakes among fruit juice consumers and non‐consumers in the UK and France: Modelling the effects of consumption of an orange pomace juice product
37. Additional file 1 of Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis
38. Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease
39. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A 2 mass in men and women with mixed dyslipidemia
40. Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
41. Saturated fats and cardiovascular health: Current evidence and controversies
42. Baseline Lipoprotein Lipids and Low-Density Lipoprotein Cholesterol Response to Prescription Omega-3 Acid Ethyl Ester Added to Simvastatin Therapy
43. Postprandial metabolism with 1,3-diacylglycerol oil versus equivalent intakes of long-chain and medium-chain triacylglycerol oils
44. Effects of Consumption of Pomegranate Juice on Carotid Intima–Media Thickness in Men and Women at Moderate Risk for Coronary Heart Disease
45. Contributors
46. Wheat Fiber in Postprandial Metabolic Profile and Health
47. Left Ventricular Mass Regression, All-Cause and Cardiovascular Mortality in Chronic Kidney Disease: A Meta-Analysis
48. Effects of Adding Prescription Omega-3 Acid Ethyl Esters to Simvastatin (20 mg/day) on Lipids and Lipoprotein Particles in Men and Women With Mixed Dyslipidemia
49. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: Results of a national survey
50. A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.